Clinical Trial Update: Enoxacin for Amyotrophic Lateral Sclerosis (ALS) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating enoxacin for amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• enoxacin (enoxacin)

Snippet

Sponsor: McGill University | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED